More importantly, we determined the impact of ANXA1 on amino acid metabolism in ICC and gained a deeper understanding of the pathogenic mechanisms in patients with ICC, thereby identifying potential therapeutic targets for ICC. This evidence concerns the gene ANXA1 and intrahepatic cholangiocarcinoma.